Contact list

  1. Home
  2. >
  3. Contact list

Below you can find the contact details for the Project Coordinator, the Co-coordinator, Financial Management, Pillar Leaders, Work Package Leaders, Task Leaders and Chemical Group Leaders. You can also download a list of all contacts in the consortium, and a list of Task Leaders. Should you identify errors or missing individuals, please email HBM4EU@eea.europa.eu to provide updated information.

Download file with list of all the HBM4EU contacts with phone numbers and e-mail addresses (see the version nr. in the file)</a >

Coordinator:

  • Marike Kolossa-Gehring Phone: +49 30 8903 1600 Mobile: +49 17 3599 3297
  • Anja Kiesow Phone: +49 30 8903 2004
  • Nicole Kobosil Phone: +49 30 8903 1269
  • Rosa Lange Phone: +49 30 8903 1357
  • Kim Pack Phone: +49 30 8903 1266
  • Lena Reiber Phone: +49 30 8903 1265
  • Pia Splanemann Phone: +49 30 8903 2793
  • Philipp Weise Phone: +49 30 8903 1222

German Environment Agency (UBA) Section II 1.2 Toxicology, Health
Related Environmental Monitoring Corrensplatz 1, 14195 Berlin POB 33 00 22,
14191 Berlin, Germany E-Mail:
HBM4EU@uba.de

Financial Management:

Birgit Puppe Phone: +49 340 2103 2366
Doreen Scheler Phone: +49 340 2103 2375
German Environment Agency (UBA) Unit Z 6 – Project Administration Wörlitzer
Platz 1, 06844 Dessau-Roßlau POB 1406, 06813 Dessau-Roßlau, Germany E-Mail:
HBM4EU@uba.de

Co-Coordinator:

Greet Schoeters Phone: + 32 14 33 5167 Mobile: +32 477427746
Sylvie Remy Phone: +32 14 33 5511
VITO-Unit Environmental Risk and Health University of Antwerp – Dept.
Biomedical Sciences University of Southern Denmark – Institute of Public
Health/ Dept. of Environmental Medicine Email:
HBM4EU@vito.be

Pillar Leaders

Pillar Leader for Pillar 1 Science to Policy:

Greet Schoeters Phone: + 32 14 33 5167 Mobile: +32 477427746 VITO-Unit
Environmental Risk and Health University of Antwerp – Dept. Biomedical
Sciences University of Southern Denmark – Institute of Public Health/ Dept.
of Environmental Medicine Email:
HBM4EU@vito.be

Pillar Leader for Pillar 2 European HBM Platform:

Argelia Castaño with co-lead Greet Schoeters Phone: +34 918223540 Mobile:
+34 918223545 National Center for Environmental Health Institute of Health
Carlos III, Ctra. Majadahonda a Pozuelo km 2,2 28220-Majadahonda (Madrid),
Spain Email: castano@isciii.es;
hbm4eu@isciii.es

Pillar Leader for Pillar 3 Exposure and Health:

Robert Barouki

Phone: 33 (0)1 42 86 20 75 Unité UMR-S 1124 Inserm-Université Paris
Descartes “Toxicologie Pharmacologie et Signalisation Cellulaire” 45 rue
des Saints Pères, 75270 Paris 06 France Email:
robert.barouki@parisdescartes.fr</a >
Phone: 33 (0)1 44 49 50 55 Service de Biochimie Métabolomique et
Protéomique Hôpital Necker Enfants Malades 149 rue de Sèvres, 75015
Paris, France Email:
robert.barouki@nck.aphp.fr</a >

List of Work Package Leaders

WP Nº Title Name Consortium Partner
1 Programme management and coordination Marike Kolossa UBA
2 Knowledge Hub Catherine Ganzleben EEA
3 Internal Calls Robert Barouki INSERM
4 Prioritisation and input to the annual work plan Catherine Ganzleben EEA
5 Translation of results into policy Greet Schoeters VITO
6 Sustainability and capacity building Robert Barouki INSERM
7 Survey design and fieldwork preparation Ulrike Fiddicke UBA
8 Targeted field work surveys and alignment at EU level Ovnair Sepai DH
9 Laboratory analysis and quality assurance Argelia Castaño ISCIII
10 Data management and analysis Greet Schoeters VITO
11 Linking HBM, health studies, and registers Hanna Tolonen THL
12 From HBM to exposure Dimosthenis Sarigiannis AUTH
13 Establishing exposure health relationships Jana Klánová MU
14 Effect Biomarkers Nicolás Olea UGR
15 Mixtures, HBM and human health risks Erik Lebret RIVM
16 Emerging Chemicals Jean-Philippe Antignac INRA
17 Ethics requirements Ulrike Doyle UBA

List of Chemical Group Leaders

CGL – partner abbr. Chemical Substance Group   Name
AUTH PAHs Denis Sarigiannis
EAA Per- and Polyfluorinated Compounds Maria Uhl, Ingrid Hauzenberger
FIOH MOCA & Anilines Tiina Santonen
UCPH MOCA & Anilines Lisbeth Knudsen
INSERM Bisphenols Robert Barouki
ISS Cadmium/Chromium VI Beatrice Bocca
JSI Cadmium/Chromium VI Milena Horvat, Janja Snoj Tratnik
MU Flame retardants Jana Klánová, Lisa Melymuk
RIVM Mixtures Erik Lebret, Mirjam Luijten
UBA Phthalates & substitutes Marike Kolossa-Gehring, Rosa Lange
VITO Emerging chemicals Greet Schoeters

List of the task Leaders

WP No. Task No. Title First Name Last name Institution
1 1.1 Overall administrative and financial management of the programme Birgit Puppe UBA
1.2 Development of the Annual Work Plans Kim Pack UBA
1.3 Coordination within and across pillars Marike Kolossa-Gehring UBA
1.4 Governing Board (GB), Stakeholder Forum (SF), and Advisory Board
(AB)
Lena Reiber UBA
1.5 Legal, IPR and ethics framework Lisbeth E. Knudsen UCPH
2 2.1 HBM4EU Website Catherine Ganzleben EEA
2.2 Strategy for the communication and dissemination of HBM4EU results Catherine Ganzleben EEA
2.3 Online Library of guidelines, biomarkers, protocols, and research
results
Susana Pedraza-Diaz ISCIII
2.4 Outreach to national, EU-level and international projects and
contacts
Catherine Ganzleben EEA
2.5 Training Paul Scheepers RUMC
4
4.1 Mapping the information needs of external bodies Catherine Ganzleben EEA
4.2 Prioritisation strategy Jean-Nicolas Ormsby ANSES
Christophe Rousselle ANSES
4.3 Rapid response mechanism Jean-Nicolas Ormsby VITO
Christophe Rousselle VITO
4.4 Drafting scoping documents to feed into the annual work plan Gudrun Koppen VITO
Greet Schoeters VITO
5
5.1 Collating results by substance Greet Schoeters VITO
5.2 Development and consolidation of EU level HBM health based guidance
values
Petra Apel UBA
5.3 Inclusion of HBM data in risk assessment/health impact assessment
strategies
Tiina Santonen FIOH
5.4 Development of indicators using HBM Joana Lobo Vicente EEA
5.5 (Phased) Action Plan for the use of HBM for policies, measures or
further research
Ilse Loots Uantwerpen
6
6.1 Establishment of national framework to feed into HBM4EU Ovnair Sepai DH
6.2 Funding mechanisms and resources for national capacity building Ana Patrícia Lopes Virgolino FMUL
6.3 Longer-term needs and expectations of stakeholders Catherine Joana Ganzleben Lobo Vicente EEA
6.4 Operational architecture concept, research cooperation framework
concept, financial plans
Robert Barouki INSERM
Charles Persoz INSERM
6.5 Indicators for measuring HBM4EU impacts Karen Vancampenhout LNE Department
Hans Reynders LNE Department
6.6 Ambassador for a long-term HBM4EU Robert Barouki INSERM
7
7.1 Identification of existing data and data gaps Ana Patrícia Lopes Virgolino FMUL
Maria Fátima Reis FMUL
Osvaldo Rodrigues dos Santos FMUL
7.2 Strategy recruitment and sampling Ulrike Fiddicke UBA
Laura-Kim Pack
7.3 Questionnaires development Marina Lacasaña EASP
7.4 Strategy for exchange of human samples Dominik Lermen IBMT
7.5 Communication of participants Andromachi Katsonouri-Sazeides MOH-CY
Elena Anastasi MOH-CY
Dora Partassides MOH-CY
8
8.1 Alignment of national studies Greet Schoeters VITO
8.2 Use of existing samples from biobanks Marika Berglund KI
Ovnair Sepai DH
8.3 Targeted fieldwork with mixtures Ovnair Lorraine Sepai Stewart DH DH
8.4 Targeted fieldwork combining HES and HBM surveys Ovnair Sepai DH
8.5 Targeted occupational studies with EU added value Tiina Santonen FIOH
8.6 Helpdesk Ovnair Sepai DH
Lorraine Stewart DH
9
9.1 Inventory of best suited biomarkers, matrices, and needs for new
analytical methods
Cathrine Thomson NIPH
Line Småstuen Haug NIPH
Enrique Manciñereas Cequier NIPH
9.2 Network of Reference HBM laboratories for performing biomarker
analysis, developing new methods, and supporting the QA/QC programme
at EU level
Argelia Castaño ISCIII
Marta Esteban López ISCIII
9.3 Developing of new methods Holger Koch IPA
9.4 Quality Assurance Thomas Göen IPASUM
9.5 Analytical Phase Thomas Lundh ULUND
Christian Lindh ULUND
9.6 Help desk Jana Hajslova VSCHT
Jana Pulkrabova VSCHT
10
10.1 Data management plan Greet Schoeters VITO
Eva Govarts VITO
Sylvie Remy VITO
10.2 Helpdesk for data management Greet Schoeters VITO
Eva Govarts VITO
Sylvie Remy VITO
10.3 Development of statistical analysis plans and coordination of
analysis
Martine Vrijheid ISGlobal
Maribel Casas ISGlobal
10.4 Data analysis including the generation of European reference values Greet Schoeters VITO
Eva Govarts VITO
Sylvie Remy VITO
10.5 Integration of data into IPChem Catherine Ganzleben EEA
11
11.1 Opportunities and obstacles for linking HBM programmen and health
studies
Anna-Maria Andersson RegionH
11.2 Standard operating procedures and guidelines for use of existing
biological samples, linking HBM and health surveys
Hanna Tolonen THL
11.3 Workshop on opportunities and obstacles to combinw HBM and health
studies
Stefaan Demarest WIV-ISP
11.4 Feasibility studies Hanna Tolonen THL
11.5 Linking HBM to administrative registries Helle Margrete Meltzer NIPH
12
12.1 Integrated external and internal exposure modelling Dimosthenis Sarigiannis AUTH
12.2 Exposure estimation from HBM data and risk characterization Dimosthenis Sarigiannis AUTH
12.3 Refinement of toxicokinetic modelling, estimation of elimination
half-lives
Jana Klánová MU
13
13.1 Knowledge base on causal pathways from chemical exposure to health
outcomes
Dimosthenis Sarigiannis AUTH
13.2 Health effects in humans based on birth and adult cohorts Thórhallur Ingi Halldórsson UI
14
14.1 Inventory of biomarkers of effect Nicolas Olea UGR
Mariana Fernández UGR
14.2 Selection of biomarkers of effect according their proven utility in
human studies
Nicolas Olea UGR
Mariana Fernández UGR
14.3 Identification of needs for the development of new biomarkers of
effect and setting up decision criteria associated with the
characteristics of biomarkers and their validation in child and
adult cohorts and occupational studies
Nicolas Olea UGR
Mariana Fernández UGR
15
15.1 Re-analysis of existing data on mixtures from earlier HBM studies
using a key set of summary indicators
Erik Lebret RIVM
15.2 Joint survey on HBM mixtures in 3-5 countries Roel Vermeulen IRAS
Jelle Vlaanderen IRAS
15.3 Identification of mixture health effects Anderas Kortenkamp UBRUN
16
16.1 Make an inventory of emerging chemicals relevant for HBM4EU and for
which to date no biomonitoring data exists
Roel Vermeulen IRAS
Jelle Vlaanderen IRAS
16.2 Method development and harmonisation of methods for (1) suspect
screening of known emerging compounds and (2) non-target screening
of yet unknown compounds
Jean-Philippe Antignac INRA
Laurent Debauwer INRA
16.3 Generation of new HBM data Adrian Covaci Uantwerpen
16.4 Identifiy emerging (mixtures of) chemicals of exposure and
toxicological concern in selected human samples
Roel Vermeulen IRAS
Jelle Vlaanderen IRAS